These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36781796)

  • 41. Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma.
    Kennedy JJ; Whiteaker JR; Ivey RG; Burian A; Chowdhury S; Tsai CF; Liu T; Lin C; Murillo OD; Lundeen RA; Jones LA; Gafken PR; Longton G; Rodland KD; Skates SJ; Landua J; Wang P; Lewis MT; Paulovich AG
    Anal Chem; 2022 Jul; 94(27):9540-9547. PubMed ID: 35767427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of proteins in urine samples using targeted mass spectrometry methods.
    Khristenko N; Domon B
    Methods Mol Biol; 2015; 1243():207-20. PubMed ID: 25384748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of novel plasma protein biomarkers to predict imminent cystic fibrosis pulmonary exacerbations using multiple reaction monitoring mass spectrometry.
    Quon BS; Dai DL; Hollander Z; Ng RT; Tebbutt SJ; Man SF; Wilcox PG; Sin DD
    Thorax; 2016 Mar; 71(3):216-22. PubMed ID: 25777587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted Proteomics as a Tool for Quantifying Urine-Based Biomarkers.
    Mohan SV; Nayakanti DS; Sathe G; George IA; Gowda H; Kumar P
    Methods Mol Biol; 2020; 2051():277-295. PubMed ID: 31552634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
    Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted Analysis of Permethylated N-Glycans Using MRM/PRM Approaches.
    Gutierrez Reyes CD; Sanni A; Mogut D; Adeniyi M; Ahmadi P; Atashi M; Onigbinde S; Mechref Y
    Methods Mol Biol; 2024; 2762():251-266. PubMed ID: 38315370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stable Isotope-Triggered Offset Fragmentation Allows Massively Multiplexed Target Profiling on Quadrupole-Orbitrap Mass Spectrometers.
    Grossegesse M; Hartkopf F; Nitsche A; Doellinger J
    J Proteome Res; 2020 Jul; 19(7):2854-2862. PubMed ID: 32369372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein biomarker discovery and fast monitoring for the identification and detection of Anisakids by parallel reaction monitoring (PRM) mass spectrometry.
    Carrera M; Gallardo JM; Pascual S; González ÁF; Medina I
    J Proteomics; 2016 Jun; 142():130-7. PubMed ID: 27195811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted Quantification of Phosphopeptides by Parallel Reaction Monitoring (PRM).
    Stolze SC; Nakagami H
    Methods Mol Biol; 2020; 2139():213-224. PubMed ID: 32462589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PRM-LIVE with Trapped Ion Mobility Spectrometry and Its Application in Selectivity Profiling of Kinase Inhibitors.
    Zhu H; Ficarro SB; Alexander WM; Fleming LE; Adelmant G; Zhang T; Willetts M; Decker J; Brehmer S; Krause M; East MP; Gray NS; Johnson GL; Kruppa G; Marto JA
    Anal Chem; 2021 Oct; 93(41):13791-13799. PubMed ID: 34606255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteomics: from hypothesis to quantitative assay on a single platform. Guidelines for developing MRM assays using ion trap mass spectrometers.
    Han B; Higgs RE
    Brief Funct Genomic Proteomic; 2008 Sep; 7(5):340-54. PubMed ID: 18579614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DPHL: A DIA Pan-human Protein Mass Spectrometry Library for Robust Biomarker Discovery.
    Zhu T; Zhu Y; Xuan Y; Gao H; Cai X; Piersma SR; Pham TV; Schelfhorst T; Haas RRGD; Bijnsdorp IV; Sun R; Yue L; Ruan G; Zhang Q; Hu M; Zhou Y; Van Houdt WJ; Le Large TYS; Cloos J; Wojtuszkiewicz A; Koppers-Lalic D; Böttger F; Scheepbouwer C; Brakenhoff RH; van Leenders GJLH; Ijzermans JNM; Martens JWM; Steenbergen RDM; Grieken NC; Selvarajan S; Mantoo S; Lee SS; Yeow SJY; Alkaff SMF; Xiang N; Sun Y; Yi X; Dai S; Liu W; Lu T; Wu Z; Liang X; Wang M; Shao Y; Zheng X; Xu K; Yang Q; Meng Y; Lu C; Zhu J; Zheng J; Wang B; Lou S; Dai Y; Xu C; Yu C; Ying H; Lim TK; Wu J; Gao X; Luan Z; Teng X; Wu P; Huang S; Tao Z; Iyer NG; Zhou S; Shao W; Lam H; Ma D; Ji J; Kon OL; Zheng S; Aebersold R; Jimenez CR; Guo T
    Genomics Proteomics Bioinformatics; 2020 Apr; 18(2):104-119. PubMed ID: 32795611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring.
    Law KP; Lim YP
    Expert Rev Proteomics; 2013 Dec; 10(6):551-66. PubMed ID: 24206228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics.
    Kitteringham NR; Jenkins RE; Lane CS; Elliott VL; Park BK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1229-39. PubMed ID: 19041286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strategies for large-scale targeted metabolomics quantification by liquid chromatography-mass spectrometry.
    Zhou J; Yin Y
    Analyst; 2016 Nov; 141(23):6362-6373. PubMed ID: 27722450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of Parallel Reaction Monitoring to the Development and Validation of a Quantitative Assay for ST-246 in Human Plasma.
    Chernonosov AA; Oleinik GA; Koval VV
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted Phosphoproteome Analysis Using Selected/Multiple Reaction Monitoring (SRM/MRM).
    Adachi J; Narumi R; Tomonaga T
    Methods Mol Biol; 2016; 1394():87-100. PubMed ID: 26700043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biomarker validation in blood specimens by selected reaction monitoring mass spectrometry of N-glycosites.
    Ossola R; Schiess R; Picotti P; Rinner O; Reiter L; Aebersold R
    Methods Mol Biol; 2011; 728():179-94. PubMed ID: 21468948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The clinical potential of prm-PASEF mass spectrometry.
    Lesur A; Dittmar G
    Expert Rev Proteomics; 2021 Feb; 18(2):75-82. PubMed ID: 33874828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.